Peytant Solutions, Inc.

At Peytant Solutions, Inc., one of our core values is Respect for the Human Tissue. We recognize the unique source of our biomaterials and commit to treating them with the utmost reverence throughout every stage of our process. This dedication drives the quality and integrity of our work, ensuring that we honor the essential role these materials play in advancing healthcare and improving lives. #Peytant #HealthCareInnovation #MedicalDevices

We’re grateful to LSI USA for the opportunity to present on Peytant Solutions, Inc.'s innovative technology to the investment community. A special thank you to our CEO, John Schorgl, for sharing our vision and innovation on stage. We were proud to represent our team’s passion, progress, and commitment to advancing care at this important investor-related event. https://lnkd.in/gTjwsbNb #Peytant #LSI #MedicalTechnology LSI

Join a team that's redefining the treatment of luminal diseases with cutting-edge medical technologies. Peytant Solutions, Inc. is growing, and we're looking for a Senior Research & Development Engineer to help drive innovation forward. If you're passionate about advancing healthcare and making a real impact, we’d love to hear from you. Apply here: https://lnkd.in/gYYbngwG 

At Peytant Solutions, Inc., our mission is clear: to fundamentally transform the treatment of luminal diseases by pioneering patented, foundational technology for covering stents with proprietary biomaterials. By focusing on innovation, we aim to reduce complications, improve quality of life, and help healthcare professionals offer more effective treatments. We’re committed to pushing the boundaries of what’s possible in stent technology and biomaterial advancements, and we’re proud to lead the way. #Peytant #MedTech #HealthTech

Tomorrow, Peytant Solutions, Inc.’s John Schorgl takes the stage at LSI USA ‘25 at 11:45 AM on Panel 16! We’re proud to showcase how Peytant Solutions, Inc. is transforming the treatment of diseases with our groundbreaking technology. Don’t miss out! https://lnkd.in/gkqyNAA5 #Peytant #LSIUSA25 #MedicalTechnology

Peytant Solutions, Inc. is honored to have our very own John Schorgl presenting at LSI USA ‘25—just four weeks away! We’re eager to showcase our technology for transforming the treatment of diseases and drive meaningful conversations. See you in March! #Peytant #LSI #MedTech

Peytant Solutions, Inc. is excited to announce the appointment of Dr. Craig Walker, MD as our Chief Medical Officer. With decades of experience in cardiovascular and peripheral vascular disease, Dr. Walker’s leadership and expertise will play a key role in driving the development and availability of our AMStent® Tracheobronchial Covered Stent System. His deep knowledge in medical innovation and commitment to education align perfectly with our mission to revolutionize treatment options for luminal disease. Read more about Dr. Walker’s appointment here: https://lnkd.in/gk9n2zWJ #Peytant #HealthCareInnovation #HealthCareTechnology

Thank you for sharing, Med-Tech Insights! #Peytant #MedTech #MedicalTechnology

Peytant Solutions, Inc. is thrilled to announce the appointment of JD Simpson as Chief Commercial Officer. With over 20 years of experience leading commercial growth in early-stage medical device companies, JD will be integral to expanding the availability of our flagship AMStent® Tracheobronchial Covered Stent System. His expertise in building high-performing organizations and driving strategic partnerships aligns perfectly with our mission to revolutionize luminal disease treatment. Read more here: https://lnkd.in/gH7JAJYe #Peytant #HealthCareLeaders #HealthTech

PRESS RELEASE – Peytant Solutions, Inc. is excited to announce the U.S. Food and Drug Administration (FDA) granted marketing authorization (clearance to market in the United States as a Class II device) for the AMStent® Tracheobronchial Covered Stent System, a novel, proprietary therapy platform. See the press release below for more information 👇 #PeytantSolutions #Peytant #DeNovo #PressRelease